Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Opening Session Panel Discussion

Welcome and Introduction to Vi3C

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




Nov
05
Today In Oncology
16 Million PRISM Trial Will Explore AI in Breast Cancer Screening
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
Study Finds Breast Cancer Risk Varies Between Different Hormonal Contraceptives
Diminishing the National Cancer Institute Threatens Americans
Zanzalintinib Plus Atezolizumab vs Regorafenib in Previously Treated Metastatic Colorectal Cancer Without MSI-H or dMMR Tumors
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo